Evaluation of Response to Therapy in Thyroid Carcinoma Patients after Radioactive Iodine Therapy [PDF]
Bagcilar Medical Bulletin, 2016 Radioactive iodine therapy is an important treatment modality for differentiated thyroid carcinoma patients. Radioactive iodine, similar to elementary iodine, is concentrated in the thyroid follicular cells after oral application, and it can damage the ...
Lebriz Uslu Besli, Ilhami Uslu
doaj +2 more sources
Radiation Recall Dermatitis following Radioactive Iodine Therapy: A New Observation
Case Reports in Oncological Medicine, 2021 A 47-year-old female, who had previously received adjuvant right breast radiation for ductal carcinoma in situ, presented with right breast edema, erythema, and pain.
Ikechukwu Chidobem +5 more
doaj +2 more sources
Hyperparathyroidism Two Years after Radioactive Iodine Therapy in an Adolescent Male [PDF]
Case Reports in Pediatrics, 2014 Primary hyperparathyroidism is a very rare complication following radioactive iodine therapy. There is typically a latency period of more than a decade following radiation exposure and, therefore, it is observed almost exclusively in adults. Consequently,
Danielle L. Gomez, Dorothy I. Shulman
doaj +2 more sources
Sarcoidosis mimicking metastatic thyroid cancer following radioactive iodine therapy [PDF]
Journal of Community Hospital Internal Medicine Perspectives, 2015 Introduction: Sarcoidosis is an inflammatory disease characterized by non-caseating granulomas that can be present in diverse organ systems. Sarcoidosis can be associated with malignancy, presenting either preceding, during, or after chemotherapy.
Zin W. Myint, Robert D. Chow
doaj +2 more sources
Low Iodine Diet for Preparation for Radioactive Iodine Therapy in Differentiated Thyroid Carcinoma in Korea [PDF]
Endocrinology and Metabolism, 2013 Preparation for radioactive iodine (RAI) therapy includes an increased serum thyroid stimulating hormone level and a low iodine diet (LID). Because of extremely high iodine intake, some physicians have advocated a more stringent LID for greater than 2 ...
Jae Hoon Chung
doaj +2 more sources
Acute myeloid leukemia following radioactive iodine therapy for papillary carcinoma of the thyroid [PDF]
Turkish Journal of Hematology, 2009 Radioactive iodine (RAI) therapy plays an important role in the management of thyroid malignancies. Leukemia is a very rare complication of radioactive therapy. There are very few case reports with doses below 100 mCi causing leukemia.
Jain Ankit +10 more
doaj +1 more source
Challenges and current views on dosing of radioactive iodine in the treatment of benign thyroid disease [PDF]
Arhiv za farmaciju, 2017 Radioactive iodine represents the significant therapeutic option in the treatment of benign thyroid disease. Despite a decades-long experience and a large number of treated patients, many issues related to the therapy with radioactive iodine are still ...
Topić-Vučenović Valentina +4 more
doaj +1 more source
São Paulo Medical Journal, 2023 BACKGROUND: The efficacy of anti-thyroid drugs in conjunction with radioactive iodine therapy in the management of Graves’ disease is still controversial.
Ikeoluwapo Kendra Bolakale-Rufai +3 more
doaj +1 more source
Radioactive iodine in the treatment of Graves' disease: history and modern concept of radionuclide therapy [PDF]
Терапевтический архив, 2022 Radioactive iodine 131I is a theranostic isotope used both for diagnosis and therapy of benign thyroid diseases and thyroid cancer for 85 years. The formation of nuclear medicine is closely linked with the use of 131I.
Marina S. Sheremeta +3 more
doaj +1 more source
Prognostic Factor Analysis for Risk-Stratified Papillary Thyroid Carcinoma and Nomogram Development for Predicting Structural Incomplete Response to Radioactive Iodine Therapy in Intermediate-Risk Patients. [PDF]
Cancer Rep (Hoboken)ABSTRACT Background Structural incomplete response (SIR) after radioactive iodine (RAI) therapy indicates persistent or recurrent structural disease and has important implications for the long‐term management of patients with papillary thyroid carcinoma (PTC).
Li Y, He Z, Zhao M, Zhang B.
europepmc +2 more sources